Efficacy and Safety of Systemic Corticosteroids for Urticaria: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Xiajing Chu, Jason Wang, Leonardo Ologundudu...
https://pubmed.ncbi.nlm.nih.gov/38642709/Actively Recruiting
Led by University of Phayao · Updated on 2026-10-05
140
Participants Needed
1
Research Sites
30 weeks
Total Duration
Researchers are evaluating whether a higher dose of cetirizine can relieve symptoms of acute urticaria hives faster than the standard dose in adults aged 18 to 60. Acute urticaria causes sudden wheals and intense itching, impacting comfort and daily life. Many people do not fully improve with the standard dose and may be prescribed corticosteroids, which can cause side effects. This trial aims to find out if increasing cetirizine to 40 mg daily is more effective and safe compared to the usual 10 mg dose. Participants are randomly assigned to one of two groups one taking the standard dose of cetirizine 10 mg once daily, and the other taking a higher dose of 20 mg twice daily total 40 mg for 7 days. Both doses are given as capsules that look alike to keep the study unbiased. Participants will record their daily symptoms, including itch and hive severity, and attend follow-up visits on Day 3, Day 7, and Week 6. Blood tests will be done before and after treatment to monitor liver and kidney function. During the study, researchers will assess how quickly symptoms resolve and changes in urticaria severity scores. They will also track the use of corticosteroids as rescue medication, quality of life changes, and any side effects experienced. Follow-up visits will check for symptom recurrence or progression to chronic urticaria. The study lasts about 6 weeks from the first dose, including treatment and follow-up, to understand both short-term effects and safety of higher dose cetirizine.
CONDITIONS
Comparing Standard-Dose and High-Dose Cetirizine for Acute Urticaria
W
Wasuchon Chaichan, MD
C
Chonlawat Chaichan, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Phayao
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 7 days
Participants take either the standard dose (10 mg once daily) or high dose (20 mg twice daily) cetirizine capsules for 7 days, recording daily symptoms.
Follow-up visits on Day 3 and Day 7
Duration - 6 weeks from first dose
Participants return for a final visit at Week 6 to assess symptom resolution and monitor safety.
1 visit at Week 6
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Xiajing Chu, Jason Wang, Leonardo Ologundudu...
https://pubmed.ncbi.nlm.nih.gov/38642709/Torsten Zuberbier, Amir Hamzah Abdul Latiff, Mohamed Abuzakouk...
https://pubmed.ncbi.nlm.nih.gov/34536239/Fariza M S Badloe, Martine Grosber, Johannes Ring...
https://pubmed.ncbi.nlm.nih.gov/38420865/Sirinda Jamjanya, Pojsakorn Danpanichkul, Sorawit Ongsupankul...
https://pubmed.ncbi.nlm.nih.gov/38280453/Yukari Okubo, Yukie Shigoka, Masashi Yamazaki...
https://pubmed.ncbi.nlm.nih.gov/21810005/University of Phayao
Lead Sponsor